Loading…
4-aroylpiperidines and 4-(α-hydroxyphenyl)piperidines as selective sigma-1 receptor ligands: synthesis, preliminary pharmacological evaluation and computational studies
Background Sigma (σ) receptors are membrane-bound proteins characterised by an unusual promiscuous ability to bind a wide variety of drugs and their high affinity for typical neuroleptic drugs, such as haloperidol, and their potential as alternative targets for antipsychotic agents. Sigma receptors...
Saved in:
Published in: | BMC chemistry 2016-08, Vol.10 (1), p.53-53, Article 53 |
---|---|
Main Authors: | , , , , , |
Format: | Article |
Language: | English |
Subjects: | |
Citations: | Items that this one cites Items that cite this one |
Online Access: | Get full text |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
cited_by | cdi_FETCH-LOGICAL-c604t-353064d3c8cd3b24f1744ecfb2c72dd923fdb734619bcf16386f665acf9d7dc93 |
---|---|
cites | cdi_FETCH-LOGICAL-c604t-353064d3c8cd3b24f1744ecfb2c72dd923fdb734619bcf16386f665acf9d7dc93 |
container_end_page | 53 |
container_issue | 1 |
container_start_page | 53 |
container_title | BMC chemistry |
container_volume | 10 |
creator | Ikome, Hermia N. Ntie-Kang, Fidele Ngemenya, Moses N. Tu, Zhude Mach, Robert H. Efange, Simon M. N. |
description | Background
Sigma (σ) receptors are membrane-bound proteins characterised by an unusual promiscuous ability to bind a wide variety of drugs and their high affinity for typical neuroleptic drugs, such as haloperidol, and their potential as alternative targets for antipsychotic agents. Sigma receptors display diverse biological activities and represent potential fruitful targets for therapeutic development in combating many human diseases. Therefore, they present an interesting avenue for further exploration. It was our goal to evaluate the potential of ring opened spipethiane (
1
) analogues as functional ligands (agonists) for σ receptors by chemical modification.
Results
Chemical modification of the core structure of the lead compound, (
1
), by replacement of the sulphur atom with a carbonyl group, hydroxyl group and 3-bromobenzylamine with the simultaneous presence of 4-fluorobenzoyl replacing the spirofusion afforded novel potent sigma-1 receptor ligands
7a–f
,
8a–f
and
9d–e
. The sigma-1 receptor affinities of
7e
,
8a
and
8f
were slightly lower than that of
1
and their selectivities for this receptor two to threefold greater than that of
1
.
Conclusions
It was found that these compounds have higher selectivities for sigma-1 receptors compared to
1
. Quantitatitive structure–activity relationship studies revealed that sigma-1 binding is driven by hydrophobic interactions.
Graphical abstract
Identified pharmacophore features for sigma binding. |
doi_str_mv | 10.1186/s13065-016-0200-1 |
format | article |
fullrecord | <record><control><sourceid>proquest_pubme</sourceid><recordid>TN_cdi_pubmedcentral_primary_oai_pubmedcentral_nih_gov_4994268</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><sourcerecordid>4204294661</sourcerecordid><originalsourceid>FETCH-LOGICAL-c604t-353064d3c8cd3b24f1744ecfb2c72dd923fdb734619bcf16386f665acf9d7dc93</originalsourceid><addsrcrecordid>eNqNks2K1TAYhosozjh6AW6k4GYEo0nz17oQZJhRYcCNgruQJl_bDGlTk_ZgL8mlN-I12c4ZhzOC4CoJ75P3--HNsqcEvyKkFK8ToVhwhIlAuMAYkXvZMZG8QITTr_cP7kfZo5SuMOYlEfJhdlRIznkpq-PsB0M6hsWPboTorBsg5XqwOUOnv36ibrExfF_GDobFv7jDpDyBBzO5HeTJtb1GJI9gYJxCzL1rV5P0Jk_LMHWQXHqZjxG8692g45KPnY69NsGH1hntc9hpP-vJheG6uAn9OE_X71VM02wdpMfZg0b7BE9uzpPsy8X557MP6PLT-49n7y6REZhNiPJ1J8xSUxpL64I1RDIGpqkLIwtrq4I2tpaUCVLVpiGClqIRgmvTVFZaU9GT7O3ed5zrHqyBYYraqzG6fm1dBe3UXWVwnWrDTrGqYoUoV4PTG4MYvs2QJtW7ZMB7PUCYkyIl47KSlLL_QAkjVDJOVvT5X-hVmOO6n40qeFWKkm3Nkz1lYkgpQnPbN8Fqy4zaZ0atmVFbZtTm_Oxw4Nsff0KyAsUeSKs0tBAPSv_T9TdP5tLi</addsrcrecordid><sourcetype>Open Access Repository</sourcetype><iscdi>true</iscdi><recordtype>article</recordtype><pqid>1825986849</pqid></control><display><type>article</type><title>4-aroylpiperidines and 4-(α-hydroxyphenyl)piperidines as selective sigma-1 receptor ligands: synthesis, preliminary pharmacological evaluation and computational studies</title><source>Publicly Available Content Database</source><source>Springer Nature - SpringerLink Journals - Fully Open Access </source><source>PubMed Central</source><source>Free Full-Text Journals in Chemistry</source><creator>Ikome, Hermia N. ; Ntie-Kang, Fidele ; Ngemenya, Moses N. ; Tu, Zhude ; Mach, Robert H. ; Efange, Simon M. N.</creator><creatorcontrib>Ikome, Hermia N. ; Ntie-Kang, Fidele ; Ngemenya, Moses N. ; Tu, Zhude ; Mach, Robert H. ; Efange, Simon M. N.</creatorcontrib><description>Background
Sigma (σ) receptors are membrane-bound proteins characterised by an unusual promiscuous ability to bind a wide variety of drugs and their high affinity for typical neuroleptic drugs, such as haloperidol, and their potential as alternative targets for antipsychotic agents. Sigma receptors display diverse biological activities and represent potential fruitful targets for therapeutic development in combating many human diseases. Therefore, they present an interesting avenue for further exploration. It was our goal to evaluate the potential of ring opened spipethiane (
1
) analogues as functional ligands (agonists) for σ receptors by chemical modification.
Results
Chemical modification of the core structure of the lead compound, (
1
), by replacement of the sulphur atom with a carbonyl group, hydroxyl group and 3-bromobenzylamine with the simultaneous presence of 4-fluorobenzoyl replacing the spirofusion afforded novel potent sigma-1 receptor ligands
7a–f
,
8a–f
and
9d–e
. The sigma-1 receptor affinities of
7e
,
8a
and
8f
were slightly lower than that of
1
and their selectivities for this receptor two to threefold greater than that of
1
.
Conclusions
It was found that these compounds have higher selectivities for sigma-1 receptors compared to
1
. Quantitatitive structure–activity relationship studies revealed that sigma-1 binding is driven by hydrophobic interactions.
Graphical abstract
Identified pharmacophore features for sigma binding.</description><identifier>ISSN: 1752-153X</identifier><identifier>EISSN: 1752-153X</identifier><identifier>EISSN: 2661-801X</identifier><identifier>DOI: 10.1186/s13065-016-0200-1</identifier><identifier>PMID: 27555879</identifier><language>eng</language><publisher>Cham: Springer International Publishing</publisher><subject>Affinity ; Chemical compounds ; Chemistry ; Chemistry and Materials Science ; Chemistry/Food Science ; Diseases ; Drugs ; Hydroxyl groups ; Ligands ; Organic and Medicinal Chemistry ; Pharmaceutical sciences ; Proteins ; Receptors ; Research Article ; Selectivity ; Sulfur</subject><ispartof>BMC chemistry, 2016-08, Vol.10 (1), p.53-53, Article 53</ispartof><rights>The Author(s) 2016</rights><lds50>peer_reviewed</lds50><oa>free_for_read</oa><woscitedreferencessubscribed>false</woscitedreferencessubscribed><citedby>FETCH-LOGICAL-c604t-353064d3c8cd3b24f1744ecfb2c72dd923fdb734619bcf16386f665acf9d7dc93</citedby><cites>FETCH-LOGICAL-c604t-353064d3c8cd3b24f1744ecfb2c72dd923fdb734619bcf16386f665acf9d7dc93</cites><orcidid>0000-0003-0795-394X</orcidid></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><linktopdf>$$Uhttps://www.proquest.com/docview/1825986849/fulltextPDF?pq-origsite=primo$$EPDF$$P50$$Gproquest$$Hfree_for_read</linktopdf><linktohtml>$$Uhttps://www.proquest.com/docview/1825986849?pq-origsite=primo$$EHTML$$P50$$Gproquest$$Hfree_for_read</linktohtml><link.rule.ids>230,314,727,780,784,885,25753,27924,27925,37012,44590,53791,53793,75126</link.rule.ids><backlink>$$Uhttps://www.ncbi.nlm.nih.gov/pubmed/27555879$$D View this record in MEDLINE/PubMed$$Hfree_for_read</backlink></links><search><creatorcontrib>Ikome, Hermia N.</creatorcontrib><creatorcontrib>Ntie-Kang, Fidele</creatorcontrib><creatorcontrib>Ngemenya, Moses N.</creatorcontrib><creatorcontrib>Tu, Zhude</creatorcontrib><creatorcontrib>Mach, Robert H.</creatorcontrib><creatorcontrib>Efange, Simon M. N.</creatorcontrib><title>4-aroylpiperidines and 4-(α-hydroxyphenyl)piperidines as selective sigma-1 receptor ligands: synthesis, preliminary pharmacological evaluation and computational studies</title><title>BMC chemistry</title><addtitle>Chemistry Central Journal</addtitle><addtitle>Chem Cent J</addtitle><description>Background
Sigma (σ) receptors are membrane-bound proteins characterised by an unusual promiscuous ability to bind a wide variety of drugs and their high affinity for typical neuroleptic drugs, such as haloperidol, and their potential as alternative targets for antipsychotic agents. Sigma receptors display diverse biological activities and represent potential fruitful targets for therapeutic development in combating many human diseases. Therefore, they present an interesting avenue for further exploration. It was our goal to evaluate the potential of ring opened spipethiane (
1
) analogues as functional ligands (agonists) for σ receptors by chemical modification.
Results
Chemical modification of the core structure of the lead compound, (
1
), by replacement of the sulphur atom with a carbonyl group, hydroxyl group and 3-bromobenzylamine with the simultaneous presence of 4-fluorobenzoyl replacing the spirofusion afforded novel potent sigma-1 receptor ligands
7a–f
,
8a–f
and
9d–e
. The sigma-1 receptor affinities of
7e
,
8a
and
8f
were slightly lower than that of
1
and their selectivities for this receptor two to threefold greater than that of
1
.
Conclusions
It was found that these compounds have higher selectivities for sigma-1 receptors compared to
1
. Quantitatitive structure–activity relationship studies revealed that sigma-1 binding is driven by hydrophobic interactions.
Graphical abstract
Identified pharmacophore features for sigma binding.</description><subject>Affinity</subject><subject>Chemical compounds</subject><subject>Chemistry</subject><subject>Chemistry and Materials Science</subject><subject>Chemistry/Food Science</subject><subject>Diseases</subject><subject>Drugs</subject><subject>Hydroxyl groups</subject><subject>Ligands</subject><subject>Organic and Medicinal Chemistry</subject><subject>Pharmaceutical sciences</subject><subject>Proteins</subject><subject>Receptors</subject><subject>Research Article</subject><subject>Selectivity</subject><subject>Sulfur</subject><issn>1752-153X</issn><issn>1752-153X</issn><issn>2661-801X</issn><fulltext>true</fulltext><rsrctype>article</rsrctype><creationdate>2016</creationdate><recordtype>article</recordtype><sourceid>PIMPY</sourceid><recordid>eNqNks2K1TAYhosozjh6AW6k4GYEo0nz17oQZJhRYcCNgruQJl_bDGlTk_ZgL8mlN-I12c4ZhzOC4CoJ75P3--HNsqcEvyKkFK8ToVhwhIlAuMAYkXvZMZG8QITTr_cP7kfZo5SuMOYlEfJhdlRIznkpq-PsB0M6hsWPboTorBsg5XqwOUOnv36ibrExfF_GDobFv7jDpDyBBzO5HeTJtb1GJI9gYJxCzL1rV5P0Jk_LMHWQXHqZjxG8692g45KPnY69NsGH1hntc9hpP-vJheG6uAn9OE_X71VM02wdpMfZg0b7BE9uzpPsy8X557MP6PLT-49n7y6REZhNiPJ1J8xSUxpL64I1RDIGpqkLIwtrq4I2tpaUCVLVpiGClqIRgmvTVFZaU9GT7O3ed5zrHqyBYYraqzG6fm1dBe3UXWVwnWrDTrGqYoUoV4PTG4MYvs2QJtW7ZMB7PUCYkyIl47KSlLL_QAkjVDJOVvT5X-hVmOO6n40qeFWKkm3Nkz1lYkgpQnPbN8Fqy4zaZ0atmVFbZtTm_Oxw4Nsff0KyAsUeSKs0tBAPSv_T9TdP5tLi</recordid><startdate>20160823</startdate><enddate>20160823</enddate><creator>Ikome, Hermia N.</creator><creator>Ntie-Kang, Fidele</creator><creator>Ngemenya, Moses N.</creator><creator>Tu, Zhude</creator><creator>Mach, Robert H.</creator><creator>Efange, Simon M. N.</creator><general>Springer International Publishing</general><general>Springer Nature B.V</general><scope>C6C</scope><scope>NPM</scope><scope>AAYXX</scope><scope>CITATION</scope><scope>3V.</scope><scope>7SR</scope><scope>7X7</scope><scope>7XB</scope><scope>8AO</scope><scope>8BQ</scope><scope>8FD</scope><scope>8FE</scope><scope>8FG</scope><scope>8FI</scope><scope>8FJ</scope><scope>8FK</scope><scope>8G5</scope><scope>ABJCF</scope><scope>ABUWG</scope><scope>AFKRA</scope><scope>AZQEC</scope><scope>BENPR</scope><scope>BGLVJ</scope><scope>CCPQU</scope><scope>D1I</scope><scope>DWQXO</scope><scope>FYUFA</scope><scope>GHDGH</scope><scope>GNUQQ</scope><scope>GUQSH</scope><scope>HCIFZ</scope><scope>JG9</scope><scope>K9.</scope><scope>KB.</scope><scope>M0S</scope><scope>M2O</scope><scope>MBDVC</scope><scope>PDBOC</scope><scope>PIMPY</scope><scope>PQEST</scope><scope>PQQKQ</scope><scope>PQUKI</scope><scope>PRINS</scope><scope>Q9U</scope><scope>7X8</scope><scope>5PM</scope><orcidid>https://orcid.org/0000-0003-0795-394X</orcidid></search><sort><creationdate>20160823</creationdate><title>4-aroylpiperidines and 4-(α-hydroxyphenyl)piperidines as selective sigma-1 receptor ligands: synthesis, preliminary pharmacological evaluation and computational studies</title><author>Ikome, Hermia N. ; Ntie-Kang, Fidele ; Ngemenya, Moses N. ; Tu, Zhude ; Mach, Robert H. ; Efange, Simon M. N.</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-LOGICAL-c604t-353064d3c8cd3b24f1744ecfb2c72dd923fdb734619bcf16386f665acf9d7dc93</frbrgroupid><rsrctype>articles</rsrctype><prefilter>articles</prefilter><language>eng</language><creationdate>2016</creationdate><topic>Affinity</topic><topic>Chemical compounds</topic><topic>Chemistry</topic><topic>Chemistry and Materials Science</topic><topic>Chemistry/Food Science</topic><topic>Diseases</topic><topic>Drugs</topic><topic>Hydroxyl groups</topic><topic>Ligands</topic><topic>Organic and Medicinal Chemistry</topic><topic>Pharmaceutical sciences</topic><topic>Proteins</topic><topic>Receptors</topic><topic>Research Article</topic><topic>Selectivity</topic><topic>Sulfur</topic><toplevel>peer_reviewed</toplevel><toplevel>online_resources</toplevel><creatorcontrib>Ikome, Hermia N.</creatorcontrib><creatorcontrib>Ntie-Kang, Fidele</creatorcontrib><creatorcontrib>Ngemenya, Moses N.</creatorcontrib><creatorcontrib>Tu, Zhude</creatorcontrib><creatorcontrib>Mach, Robert H.</creatorcontrib><creatorcontrib>Efange, Simon M. N.</creatorcontrib><collection>Springer Nature OA/Free Journals</collection><collection>PubMed</collection><collection>CrossRef</collection><collection>ProQuest Central (Corporate)</collection><collection>Engineered Materials Abstracts</collection><collection>Health & Medical Collection</collection><collection>ProQuest Central (purchase pre-March 2016)</collection><collection>ProQuest Pharma Collection</collection><collection>METADEX</collection><collection>Technology Research Database</collection><collection>ProQuest SciTech Collection</collection><collection>ProQuest Technology Collection</collection><collection>Hospital Premium Collection</collection><collection>Hospital Premium Collection (Alumni Edition)</collection><collection>ProQuest Central (Alumni) (purchase pre-March 2016)</collection><collection>Research Library (Alumni Edition)</collection><collection>Materials Science & Engineering Collection</collection><collection>ProQuest Central (Alumni)</collection><collection>ProQuest Central UK/Ireland</collection><collection>ProQuest Central Essentials</collection><collection>ProQuest Central</collection><collection>Technology Collection</collection><collection>ProQuest One Community College</collection><collection>ProQuest Materials Science Collection</collection><collection>ProQuest Central Korea</collection><collection>Health Research Premium Collection</collection><collection>Health Research Premium Collection (Alumni)</collection><collection>ProQuest Central Student</collection><collection>Research Library Prep</collection><collection>SciTech Premium Collection</collection><collection>Materials Research Database</collection><collection>ProQuest Health & Medical Complete (Alumni)</collection><collection>Materials Science Database</collection><collection>Health & Medical Collection (Alumni Edition)</collection><collection>ProQuest research library</collection><collection>Research Library (Corporate)</collection><collection>Materials Science Collection</collection><collection>Publicly Available Content Database</collection><collection>ProQuest One Academic Eastern Edition (DO NOT USE)</collection><collection>ProQuest One Academic</collection><collection>ProQuest One Academic UKI Edition</collection><collection>ProQuest Central China</collection><collection>ProQuest Central Basic</collection><collection>MEDLINE - Academic</collection><collection>PubMed Central (Full Participant titles)</collection><jtitle>BMC chemistry</jtitle></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext</fulltext></delivery><addata><au>Ikome, Hermia N.</au><au>Ntie-Kang, Fidele</au><au>Ngemenya, Moses N.</au><au>Tu, Zhude</au><au>Mach, Robert H.</au><au>Efange, Simon M. N.</au><format>journal</format><genre>article</genre><ristype>JOUR</ristype><atitle>4-aroylpiperidines and 4-(α-hydroxyphenyl)piperidines as selective sigma-1 receptor ligands: synthesis, preliminary pharmacological evaluation and computational studies</atitle><jtitle>BMC chemistry</jtitle><stitle>Chemistry Central Journal</stitle><addtitle>Chem Cent J</addtitle><date>2016-08-23</date><risdate>2016</risdate><volume>10</volume><issue>1</issue><spage>53</spage><epage>53</epage><pages>53-53</pages><artnum>53</artnum><issn>1752-153X</issn><eissn>1752-153X</eissn><eissn>2661-801X</eissn><abstract>Background
Sigma (σ) receptors are membrane-bound proteins characterised by an unusual promiscuous ability to bind a wide variety of drugs and their high affinity for typical neuroleptic drugs, such as haloperidol, and their potential as alternative targets for antipsychotic agents. Sigma receptors display diverse biological activities and represent potential fruitful targets for therapeutic development in combating many human diseases. Therefore, they present an interesting avenue for further exploration. It was our goal to evaluate the potential of ring opened spipethiane (
1
) analogues as functional ligands (agonists) for σ receptors by chemical modification.
Results
Chemical modification of the core structure of the lead compound, (
1
), by replacement of the sulphur atom with a carbonyl group, hydroxyl group and 3-bromobenzylamine with the simultaneous presence of 4-fluorobenzoyl replacing the spirofusion afforded novel potent sigma-1 receptor ligands
7a–f
,
8a–f
and
9d–e
. The sigma-1 receptor affinities of
7e
,
8a
and
8f
were slightly lower than that of
1
and their selectivities for this receptor two to threefold greater than that of
1
.
Conclusions
It was found that these compounds have higher selectivities for sigma-1 receptors compared to
1
. Quantitatitive structure–activity relationship studies revealed that sigma-1 binding is driven by hydrophobic interactions.
Graphical abstract
Identified pharmacophore features for sigma binding.</abstract><cop>Cham</cop><pub>Springer International Publishing</pub><pmid>27555879</pmid><doi>10.1186/s13065-016-0200-1</doi><tpages>1</tpages><orcidid>https://orcid.org/0000-0003-0795-394X</orcidid><oa>free_for_read</oa></addata></record> |
fulltext | fulltext |
identifier | ISSN: 1752-153X |
ispartof | BMC chemistry, 2016-08, Vol.10 (1), p.53-53, Article 53 |
issn | 1752-153X 1752-153X 2661-801X |
language | eng |
recordid | cdi_pubmedcentral_primary_oai_pubmedcentral_nih_gov_4994268 |
source | Publicly Available Content Database; Springer Nature - SpringerLink Journals - Fully Open Access ; PubMed Central; Free Full-Text Journals in Chemistry |
subjects | Affinity Chemical compounds Chemistry Chemistry and Materials Science Chemistry/Food Science Diseases Drugs Hydroxyl groups Ligands Organic and Medicinal Chemistry Pharmaceutical sciences Proteins Receptors Research Article Selectivity Sulfur |
title | 4-aroylpiperidines and 4-(α-hydroxyphenyl)piperidines as selective sigma-1 receptor ligands: synthesis, preliminary pharmacological evaluation and computational studies |
url | http://sfxeu10.hosted.exlibrisgroup.com/loughborough?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2025-01-04T15%3A11%3A23IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-proquest_pubme&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.genre=article&rft.atitle=4-aroylpiperidines%20and%204-(%CE%B1-hydroxyphenyl)piperidines%20as%20selective%20sigma-1%20receptor%20ligands:%20synthesis,%20preliminary%20pharmacological%20evaluation%20and%20computational%20studies&rft.jtitle=BMC%20chemistry&rft.au=Ikome,%20Hermia%20N.&rft.date=2016-08-23&rft.volume=10&rft.issue=1&rft.spage=53&rft.epage=53&rft.pages=53-53&rft.artnum=53&rft.issn=1752-153X&rft.eissn=1752-153X&rft_id=info:doi/10.1186/s13065-016-0200-1&rft_dat=%3Cproquest_pubme%3E4204294661%3C/proquest_pubme%3E%3Cgrp_id%3Ecdi_FETCH-LOGICAL-c604t-353064d3c8cd3b24f1744ecfb2c72dd923fdb734619bcf16386f665acf9d7dc93%3C/grp_id%3E%3Coa%3E%3C/oa%3E%3Curl%3E%3C/url%3E&rft_id=info:oai/&rft_pqid=1825986849&rft_id=info:pmid/27555879&rfr_iscdi=true |